Lead Product(s) : Sestamibi
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Astellas Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Half-Dose Radiopharmaceutical in Wide Beam Reconstruction
Details : Cardiolite (99m-Tc Sestamibi) is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Myocardial Infarction.
Product Name : Cardiolite
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 26, 2011
Lead Product(s) : Sestamibi
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Astellas Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
